[Drug treatment of psychological alterations in inflammatory bowel disease: application by the gastroenterologist].
As in other chronic diseases, in inflammatory bowel disease (IBD) there is a high prevalence of emotional disorders. Patients' quality of life and wellbeing are closely related to symptoms of anxiety and depression - hence the importance of a comprehensive approach to this disease. Among the available pharmacological options, anxiolytics and selective serotonin reuptake inhibitors (SSRI) are considered to be effective drugs that are easily administered and show excellent safety and tolerability. The present article provides a practical description of the characteristics of these compounds to indicate when, how and for how long a pharmacological approach should be used. In general, benzodiazepines are the drugs of choice in short-term treatments. SSRI are preferred in long-term treatments, whether for anxiety of depression, with the recommendation that treatment be maintained for at least 1 year.
Bedmar Noguerol
Marta
M
Psiquiatra de la Unidad de Salud Mental Infanto-Juvenil, Hospital Cruz Roja, Palma de Mallorca, España. martabedmar@yahoo.es
D001007:Anxiety / Q000188:drug therapy* / Q000209:etiology*; D001569:Benzodiazepines / Q000627:therapeutic use; D003863:Depression / Q000188:drug therapy* / Q000209:etiology*; D005762:Gastroenterology; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000150:complications*; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use
D001569:Benzodiazepines; D017367:Selective Serotonin Reuptake Inhibitors